-5%
Marzev is prescribed for adults with type 2 diabetes to help manage blood sugar levels.
Omarigliptin is a long-acting inhibitor of the enzyme Dipeptidyl Peptidase-4 (DPP-4). DPP-4 breaks down incretin hormones, which play a key role in regulating blood glucose by stimulating insulin release and reducing glucagon secretion after meals. By inhibiting DPP-4, Omarigliptin enhances the activity of incretin hormones, helping to maintain proper blood sugar levels.